Several strategies have proven effective in reducing transmission of HIV, including access to confidential testing and counseling, early introduction of HIV medications, and male circumcision. Three new studies show what actually affects the spread of HIV in populations, and results vary between different African settings.
Researchers with the University of North Carolina at Chapel Hill and the Centers for Disease Control and Prevention are examining a new drug delivery system that uses dolutegravir, an established HIV drug, in a potential longacting treatment and prevention system. The system has been tested in animal models.
Early research is focusing on a capsule that can deliver a week’s worth of HIV drugs in a single dose. If confirmed in advanced research, such an option could allow patients to stay compliant with the dosing regimen required to fight the virus successfully.